MJP Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
MJP Associates's LLY Position: Q1 2026 in Review
MJP Associates increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $387K and bringing the position to 3,732 shares worth $3.43M. The position accounts for 0.42% of the portfolio, ranked #35.
MJP Associates first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.6M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- MJP Associates held 3,732 shares of Eli Lilly worth $3.43M as of Q1 2026.
- MJP Associates bought 382 Eli Lilly shares in Q1 2026, an estimated $387K.
- Eli Lilly made up 0.42% of MJP Associates's portfolio in Q1 2026, its #35 holding.
- MJP Associates first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- MJP Associates's Eli Lilly position peaked at $3.6M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.